Xenia 10 Tablet

Xenia 10 is effective in reducing both fasting and postprandial blood glucose concentrations and has been shown to contribute to weight reduction and modest blood pressure lowering effects. It may be used as monotherapy or in combination with other antidiabetic agents, including metformin, sulfonylureas, or insulin. Clinical trials have demonstrated that Empagliflozin also offers cardiovascular benefits, including reduced risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease.

Common adverse effects include urinary tract infections, genital mycotic infections, and increased urination. It is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, severe renal impairment, or hypersensitivity to the drug. Regular monitoring of renal function and blood glucose levels is recommended during therapy with Xenia 10 Tablet.